Trials / Completed
CompletedNCT02676011
Brad Arrhythmia Induced by Repeated Succinylcholine During Gynecological Laparoscopic Surgery
Prevention of Brad Arrhythmia Induced by Repeated Succinylcholine by Atropine Sulfate During Gynecological Laparoscopic Surgery: a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Cardiac arrhythmias are a well-recognized complication of anesthesia for laparoscopy. The aim of this study was to evaluate the efficacy of atropine sulfate for prevention of brad arrhythmia induced by repeated succinylcholine during gynecological laparoscopic surgery.
Detailed description
120 candidates, ASA 1 in the age range 18-40 years scheduled for elective diagnostic gynecological laparoscopic surgery were randomly assigned into 4 groups to receive either atropine sulfate or normal saline solution (as placebo).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IM atropine | Atropine (0.01 mg/kg) (1 ml) IM 30 minutes before induction of anesthesia |
| DRUG | IV atropine | Atropine (0.01 mg/kg) intravenously (10 ml) 3 minutes before induction of anesthesia |
| DRUG | Atropine mixed with second dose succinylcholine | Atropine (0.01 mg/kg) added to the second dose succinylcholine (1mg/kg) prepared to 5 ml syringe with normal saline |
| DRUG | IM normal saline | 1 ml normal saline IM 30 minutes before induction of anesthesia |
| DRUG | IV normal saline | IV 10 ml normal saline 3 minutes before induction of anesthesia |
| DRUG | Normal saline mixed with second dose succinylcholine | Second dose succinylcholine (1 mg/kg) prepared to 5 ml syringe with normal saline |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2016-02-05
- Last updated
- 2016-09-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02676011. Inclusion in this directory is not an endorsement.